Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections

Authors:
  • JQJunyan Qu
    Junyan Qu
  • MQMin Quan
    Min Quan
  • FQFu Qiao
    Fu Qiao
  • HBHazrat Bilal
    Hazrat Bilal
  • WFWenjie Fang
    Wenjie Fang
  • BXBin Xu
    Bin Xu
  • YCYijian Chen
    Yijian Chen
  • JLJing Liu
    Jing Liu
  • HPHong Peng
    Hong Peng
  • JPJue Pan
    Jue Pan
  • LGLi Gu
    Li Gu

Top Cited Papers
Open Access
Abstract
The epidemiological patterns of respiratory viruses are complex and highly diverse. Infections caused particularly by SARS-CoV-2 and influenza viruses are frequently followed by secondary mucormycosis, posing significant challenges to clinical management and public health. To address the challenges posed by secondary mucormycosis following respiratory viral infections, the Fungal Prevention and Control Team of the Center for Infectious Diseases at West China Hospital, Sichuan University, convened experts from relevant disciplines across the world, to develop the "Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections". This consensus aims to provide systematic guidance and optimize prevention strategies. It identifies high-risk populations for mucormycosis after respiratory viral infections and offers 12 preventive recommendations focusing on four areas: education and training, personal protection, early diagnosis and treatment, and infection control. The document also highlights key measures that remain controversial or insufficiently supported by evidence and outlines directions for future research to promote greater awareness and investigation of mucormycosis.